MarketPeel
Insider Trading Intelligence
AR

Amit Rakhit

OVID
PRESIDENT AND CMO · OVID THERAPEUTICS INC. · CIK 0001704636
FILING MIX · LIFETIME75%/25%
BUYS
3
SELLS
1
TOTAL VALUE
$190.5K
COMPANIES
1
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
760,840
AVG SELL PX
$3.71
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Amit Rakhit, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+6.56%-0.39%+6.94%+6.94%
14d1+0.00%+3.83%+0.60%+3.23%+3.23%
30d1+0.00%+10.38%+2.22%+8.16%+8.16%
60d1+100.00%-4.92%+2.37%-7.29%-7.29%
90d1+0.00%+1.91%-0.28%+2.19%+2.19%
180d1+100.00%-13.66%+7.43%-21.09%-21.09%
1y1+100.00%-45.08%-12.13%-32.95%-32.95%
2y1+100.00%-7.38%+6.17%-13.54%-13.54%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OVID · 760,840 shares · as of Jul 14, 2021
0190,210380,420570,630760,8402021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
FLOW · 3 buys / 1 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
OVID
OVID THERAPEUTICS INC.
SALE
President and CMO
34,017$3.71$126.2K726,823Jul 14, 2021Jul 16, 2021
OVID
OVID THERAPEUTICS INC.
PURCHASE
President and CMO
34,01790,983Jul 14, 2021Jul 16, 2021
OVID
OVID THERAPEUTICS INC.
PURCHASE
President and CMO
34,017$1.89$64.3K760,840Jul 14, 2021Jul 16, 2021
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
200,000200,000Dec 17, 2020Dec 21, 2020
Other insiders · OVID
Loading peer insiders…
About this filer
CIK 0001704636
ROLE
President and CMO
PRIMARY
OVID
COMPANIES
1
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001704636DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback